Catalyst Wire Dossier Catalyst Wire Dossier

JDS-HF3.0 Supplement

· Bonafide Health
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JDS-HF3.0 Supplement, covering 2025-11-20 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women [NA]

See pricing